Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.
about
Therapeutic Approach to Adult Fibrotic Lung DiseasesTreatment of rheumatoid arthritis-associated interstitial lung disease: a perspective reviewManagement of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary FibrosisUp-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung DiseaseThe multifaceted aspects of interstitial lung disease in rheumatoid arthritisA roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung diseaseAssociation of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitopeExtraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients.Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease.Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients.Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD.Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes.Clinical features of rheumatoid arthritis-associated interstitial lung disease.Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung diseaseIncidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study.Co-morbidity in patients with early rheumatoid arthritis - inflammation mattersPulmonary involvement in rheumatoid arthritis: A cross-sectional study in Iran.Demographic and disease-related predictors of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population.Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrosClinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF).Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?Predictors of mortality in rheumatoid arthritis-related interstitial lung disease.Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review.Respiratory symptoms in rheumatoid arthritis: relation to pulmonary abnormalities detected by high-resolution CT and pulmonary functional testing.Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review.Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.Association of human leukocyte antigen alleles with chronic lung diseases in rheumatoid arthritis.Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study.Establishment of a Rat Adjuvant Arthritis-Interstitial Lung Disease Model.Preclinical lung disease in early rheumatoid arthritis.Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Concepts.Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.High-resolution computed tomography and rheumatoid arthritis: semi-quantitative evaluation of lung damage and its correlation with clinical and functional abnormalities.
P2860
Q26741569-1252F62F-CF30-4094-A41E-A1011C623111Q26775753-E2249E9B-9C5E-453E-B0C9-2446786B05B7Q26781712-093560B3-BFFF-43AF-A979-100F70884E67Q26825098-62CDDD92-6179-4E14-A8C9-98DF6490CDAEQ26861557-CBDEC9B4-2B64-450D-A3CC-D21E5F30B62AQ27014138-22CDD150-816F-42D3-A4F2-7C00AC54326FQ28730083-11E781B1-E068-4743-AF35-B70D04FF16E6Q33637585-CB1CA42D-B4FD-4312-8D60-27B576B5122AQ33717110-48732854-FA35-47FF-9A7E-5028B010AE21Q34584869-5FF6D8E1-FC50-4975-95FF-36F4984437A4Q35151573-1E18273D-BADE-4298-9A0E-0C88313EDBFFQ35179712-641FB503-1286-44F2-B16E-267C8011C5E0Q35649228-A8B2E82A-8D60-428F-8061-0434879B8107Q35962818-9D5A883D-668F-4BC0-8920-78C7F977EF77Q36086758-DC20E534-B89F-49F8-911F-D9010273C137Q36128529-A3BA8AA4-9005-4C2C-943A-901F637926FDQ36254510-501B7963-8FC9-4DB0-83AF-8BD1232DE0BEQ36270376-1B09DDA4-0870-411B-965C-1B52C74F5993Q36513993-A99ACEFC-71BB-411B-AD47-BDD74286E4B3Q36566210-B5B8DA6D-183B-4A46-A267-72FB388C785AQ37130290-69FA691B-F672-44A3-97C1-C48DC1C99B48Q37220222-161F5430-F199-4E8B-9848-22F585062C81Q37498876-3CD3A278-3A42-4BBB-9221-4DF3F9415BEAQ37586580-A95DF5E9-FF71-423C-954E-4A88A299F2EFQ38174219-8D820635-5140-4B94-8D1F-F4FAB6C4730AQ38191199-AD9176EA-B47B-46AB-8405-CA20301CA288Q38787176-A666764A-FCA2-4212-AF37-1A58304D1A72Q38979114-7B83AB24-7819-46F2-BA67-86BD8348EDF5Q39618633-7C11679C-9871-4ED5-8663-B058095473E6Q40050518-CDC8E93E-8BCD-4942-A728-C0F06DFCDA18Q40338691-9C799FBA-9029-4840-8555-1D3E5BCA7645Q40816137-D50F4CEB-3618-4873-A607-467299AC8B5FQ41840744-D0B9B416-E24B-4C94-97B7-C4FA4D36B49EQ42178383-7ABDE522-4B4F-45C4-8932-8CBB72B47A28Q47096098-BB8ABA23-62EE-4BBD-9EDC-7F26758C7311Q47940789-6FBE6B41-7BEE-4B80-AABE-4DAA93499684Q47943679-FE4782BD-D5B8-4265-B1A2-94B2766A4BF5Q50101241-59440A41-2742-47A6-899C-F0F417E37B3EQ51144192-03475C5E-9B43-4605-A8D9-0DC212EB76BAQ51581295-3EA57F50-D80F-41E3-BF73-39BA136F3D0E
P2860
Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Interstitial lung disease has ...... ults from an inception cohort.
@en
Interstitial lung disease has ...... ults from an inception cohort.
@nl
type
label
Interstitial lung disease has ...... ults from an inception cohort.
@en
Interstitial lung disease has ...... ults from an inception cohort.
@nl
prefLabel
Interstitial lung disease has ...... ults from an inception cohort.
@en
Interstitial lung disease has ...... ults from an inception cohort.
@nl
P2093
P2860
P356
P1433
P1476
Interstitial lung disease has ...... sults from an inception cohort
@en
P2093
Adam Young
Andrew Gough
ERAS (Early Rheumatoid Arthritis Study)
Gouri Koduri
Joe Devlin
John Winfield
Josh Dixey
Paul Davies
Peter Prouse
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ035
P50
P577
2010-03-11T00:00:00Z